Literature DB >> 28295216

Genetic alterations in TRAF3 and CYLD that regulate nuclear factor κB and interferon signaling define head and neck cancer subsets harboring human papillomavirus.

Tony Chen1, Jialing Zhang1, Zhong Chen1, Carter Van Waes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28295216      PMCID： PMC5419858          DOI： 10.1002/cncr.30659

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

Review 1.  Expanding TRAF function: TRAF3 as a tri-faced immune regulator.

Authors:  Hans Häcker; Ping-Hui Tseng; Michael Karin
Journal:  Nat Rev Immunol       Date:  2011-06-10       Impact factor: 53.106

Review 2.  NF-κB and the link between inflammation and cancer.

Authors:  Joseph A DiDonato; Frank Mercurio; Michael Karin
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 3.  CYLD-mediated signaling and diseases.

Authors:  Bryan J Mathis; Yimu Lai; Chen Qu; Joseph S Janicki; Taixing Cui
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 4.  Nuclear factor-kappaB in development, prevention, and therapy of cancer.

Authors:  Carter Van Waes
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

5.  CYLD and HCC: when being too sensitive to your dirty neighbors results in self-destruction.

Authors:  Joan Font-Burgada; Ekihiro Seki; Michael Karin
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

6.  Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.

Authors:  Tanguy Y Seiwert; Zhixiang Zuo; Michaela K Keck; Arun Khattri; Chandra S Pedamallu; Thomas Stricker; Christopher Brown; Trevor J Pugh; Petar Stojanov; Juok Cho; Michael S Lawrence; Gad Getz; Johannes Brägelmann; Rebecca DeBoer; Ralph R Weichselbaum; Alexander Langerman; Louis Portugal; Elizabeth Blair; Kerstin Stenson; Mark W Lingen; Ezra E W Cohen; Everett E Vokes; Kevin P White; Peter S Hammerman
Journal:  Clin Cancer Res       Date:  2014-07-23       Impact factor: 12.531

7.  Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.

Authors:  Clint Allen; Kunal Saigal; Liesl Nottingham; Pattatheyil Arun; Zhong Chen; Carter Van Waes
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

8.  Comprehensive genomic characterization of head and neck squamous cell carcinomas.

Authors: 
Journal:  Nature       Date:  2015-01-29       Impact factor: 49.962
  8 in total
  3 in total

1.  NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer.

Authors:  Travis P Schrank; Andrew C Prince; Tejas Sathe; Xiaowei Wang; Xinyi Liu; Damir T Alzhanov; Barbara Burtness; Albert S Baldwin; Wendell G Yarbrough; Natalia Issaeva
Journal:  Oncotarget       Date:  2022-05-24

2.  Human papillomavirus and the landscape of secondary genetic alterations in oral cancers.

Authors:  Maura L Gillison; Keiko Akagi; David E Symer; Weihong Xiao; Bo Jiang; Robert K L Pickard; Jingfeng Li; Benjamin J Swanson; Amit D Agrawal; Mark Zucker; Birgit Stache-Crain; Anne-Katrin Emde; Heather M Geiger; Nicolas Robine; Kevin R Coombes
Journal:  Genome Res       Date:  2018-12-18       Impact factor: 9.043

Review 3.  Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis.

Authors:  Xiu Yin; Qingbin Liu; Fen Liu; Xinchen Tian; Tinghao Yan; Jie Han; Shulong Jiang
Journal:  Front Cell Dev Biol       Date:  2022-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.